You do understand the reason TRXC will tank is because of the design of the platform. The other robot is a completely different design. It's funny because TRXC was trying to be a single port robotic company but failed FDA. Pope used to pump Surgibot as a portable single incision robot with a small footprint. He even used to say what is great about Surgibot is the Hospital doesn't have to dedicate an entire OR with a large platform. That was before they acquired Alf-x. He said there was a 2 million case market for single port Surgibot. That future will be met by another single port entry.